Project Grant HT94252510988
Award Date 9/1/25
Completion Date 8/31/29
Dollars Obligated $1.5M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
- The U.S. Department of the Army Medical Command awarded a $1,277,097 Project Grant to Oregon Health & Science University (OHSU) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "GLIMPSE-PD: GLYMPHATICS IMAGING TO PROBE SLEEP IN PARKINSON'S DISEASE," aims to support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The project will run from Sep...
- This Project Grant award of $2,358,273.00 from the U.S. Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Oregon Health & Science University (OHSU) to investigate "Postural Motor Activation Deficits After MTBI: Translating Laboratory Findings to Clinical Care". The research project aims to advance understanding of postural control deficits following mild traumatic brain injuries (MTBI) and translate laboratory...
- The Oregon Health & Science University was awarded a $249,308 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of April 1, 2021 through March 31, 2024. The grant aims to support research titled "IANAM: THE ABILITY TO "VISUALIZE" HEADACHE, SLEEP DISTURBANCE, AND MTBI" which investigates medical solutions for conditions experienced by military service members, such as traumatic brain...
- This $1,000,000.00 federal Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research focused on investigating whether the gut microbiome coordinates with the gut-brain axis to contribute to behavioral alterations and cognitive injuries following traumatic brain injury (TBI), and if these effects are more profound in individuals with the APOE E4 genetic variant. The prime...
- This federal Project Grant award of $1,314,065.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research on the dose-response relationship of acute traumatic brain injury (TBI) blood biomarkers with pathoanatomic neuroimaging findings. The project will be conducted by the University of California, San Francisco (UCSF) over a period of 3 years from September 1, 2025 to August 31, 2028. The research...
- This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $2,375,394.00 to the University of Virginia to employ ultrahigh-gradient strength MRI in developing an imaging biomarker for interface astroglial scarring in blast-exposed military personnel. The award period runs from November 1, 2025 to October 31, 2028. The objective is to transform healthcare for military service members and the broader public...
- This $691,213 Project Grant from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), supports research into bioengineered 3D human brain systems to investigate risk factors, mechanisms, and treatments for traumatic brain injury-induced Alzheimer's disease. Tufts University is the primary awardee and will conduct research. Massachusetts General Hospital will provide $691,213 in research services as a sub-awardee. The overarching...
- The Washington University Office of Sponsored Research Services Division was awarded a $1,377,119 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct the study "AD GENETIC RISK AS A PROGNOSTIC FACTOR FOR COGNITIVE OUTCOMES AFTER TBI" over a 4-year period from September 2024 to September 2028. This federal grant supports innovative biomedical research aimed at improving health outcomes for military service...
- The Defense Health Agency awarded a $3.755 million Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to investigate dual orexin antagonist treatment to prevent neurobehavioral sequelae of traumatic brain injury from April 1, 2023 to March 31, 2027. The Military Medical Research and Development program supports innovative medical research to improve warfighter health and transform public healthcare. Under this award,...
- This federal Project Grant award of $249,999.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is supporting research conducted by the University of Maryland, Baltimore (UMB) to gain insights into multiple sclerosis pathology. The research project will leverage 7-T MRI and multiomics analysis of serologic samples to advance the understanding of this neurological disorder. The award period runs from August 15, 2024 to August 14,...